Enfusion share price today

(ENFN)

Enfusion share price is $10.69 & ₹911.54 as on 27 Dec 2024, 2.30 'hrs' IST

$10.69

▲

0.11

(1.04%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Enfusion share price in Dollar and Rupees. Guide to invest in Enfusion from India. Also see the sentimental analysis on Indian investors investing in Enfusion. Get details on the Indian mutual funds that are investing in Enfusion. Get Analyst recommendations and forecasts along with all the Enfusion's financials.

Enfusion share price movements

Today's Low: $10.48
Today's High: $11.03
$10.69
1.96%
Downside
Day's Volatility :4.99%
Upside
3.08%
52 Weeks Low: $7.52
52 Weeks High: $11.38
$10.69
29.65%
Downside
52 Weeks Volatility :33.89%
Upside
6.02%

Enfusion Returns

Period	Enfusion Inc	Sector (Technology)	Index (Russel 2000)
3 Months	11.72%	5.9%	0.0%
6 Months	24.18%	6.3%	0.0%
1 Year	7.63%	24.7%	0.0%
3 Years	-46.78%	39.1%	-21.1%

Enfusion Key Statistics

in dollars & INR

Previous Close	$10.58
Open	$10.55
Today's High	$11.03
Today's Low	$10.48
Market Capitalization	$998.5M
Today's Volume	$142.0K
52 Week High	$11.375
52 Week Low	$7.52
Revenue TTM	$195.2M
EBITDA	$18.5M
Earnings Per Share (EPS)	$0.04
PE Ratio	264.5
Profit Margin	1.7%
Quarterly Earnings Growth YOY	-0.27%
Return On Equity TTM	5.48%

How to invest in Enfusion from India?

It is very easy for Indian residents to invest directly in Enfusion from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Enfusion stock in both Indian Rupees (INR) and US Dollars (USD). Search for Enfusion or ENFN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Enfusion or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Enfusion shares which would translate to 0.080 fractional shares of Enfusion as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Enfusion, in just a few clicks!

Returns in Enfusion for Indian investors in Rupees

Investment Value

₹1,00,000

Enfusion investment value today

Current value as on today

₹1,11,074

Returns

₹11,074

(+11.07%)

Returns from Enfusion Stock

₹8,749 (+8.75%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Enfusion

-9%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Enfusion on INDmoney from India has reduced in the last 30 days as on Dec 27, 2024. -9% less investors are searching Enfusion in the last 30 days versus the previous period.

Global Institutional Holdings in Enfusion

ICONIQ Capital, LLC
14.88%
Brown Capital Management, LLC
7.64%
Hillhouse Capital Advisors, Ltd.
5.27%
Vanguard Group Inc
4.26%
BlackRock Inc
3.26%
Ararat Capital Management, LP
2.73%

Analyst Recommendation on Enfusion

Sell

23%Buy

30%Hold

46%Sell

Based on 13 Wall street analysts offering stock ratings for Enfusion(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Enfusion

What analysts predicted

Downside of 7.46%

Current:

$10.69

Target:

$9.89

Insights on Enfusion

Price Movement
In the last 1 month, ENFN stock has moved up by 4.4%
Increasing Revenue
Revenue is up for the last 17 quarters, 19.78M → 51.16M (in $), with an average increase of 5.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 1.82M → 1.41M (in $), with an average decrease of 22.5% per quarter
ENFN vs NOW (1 yr)
In the last 1 year, Servicenow, Inc. has given 57.7% return, outperforming this stock by 50.4%
ENFN vs NOW (3 yr)
In the last 3 years, Servicenow, Inc. has given 70.5% return, outperforming this stock by 115.0%
Price to Sales
ForENFN every $1 of sales, investors are willing to pay $4.9, whereas for Servicenow, Inc., the investors are paying $21.7 for every $1 of sales.

Enfusion Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$59.0M	-
Net Income	$12.7M	-
Net Profit Margin	21.44%	-

	FY20	Y/Y Change
Revenue	$79.6M	↑ 34.79%
Net Income	$4.1M	↓ 67.91%
Net Profit Margin	5.1%	↓ 16.34%

	FY21	Y/Y Change
Revenue	$111.7M	↑ 40.39%
Net Income	$-282.2M	↓ 7050.06%
Net Profit Margin	-252.68%	↓ 257.78%

	FY22	Y/Y Change
Revenue	$150.3M	↑ 34.6%
Net Income	$-13.3M	↓ 95.3%
Net Profit Margin	-8.82%	↑ 243.86%

	FY23	Y/Y Change
Revenue	$174.5M	↑ 16.09%
Net Income	$6.0M	↓ 145.43%
Net Profit Margin	3.45%	↑ 12.27%

	Q2 FY23	Q/Q Change
Revenue	$42.7M	↑ 4.27%
Net Income	$629.0K	↓ 86.6%
Net Profit Margin	1.47%	↓ 9.99%

	Q3 FY23	Q/Q Change
Revenue	$44.4M	↑ 3.83%
Net Income	$1.8M	↑ 190.62%
Net Profit Margin	4.12%	↑ 2.65%

	Q4 FY23	Q/Q Change
Revenue	$46.5M	↑ 4.8%
Net Income	$623.0K	↓ 65.92%
Net Profit Margin	1.34%	↓ 2.78%

	Q1 FY24	Q/Q Change
Revenue	$48.1M	↑ 3.37%
Net Income	$-539.0K	↓ 186.52%
Net Profit Margin	-1.12%	↓ 2.46%

	Q2 FY24	Q/Q Change
Revenue	$49.5M	↑ 2.92%
Net Income	$1.8M	↓ 438.78%
Net Profit Margin	3.69%	↑ 4.81%

	Q3 FY24	Q/Q Change
Revenue	$51.2M	↑ 3.46%
Net Income	$1.4M	↓ 22.51%
Net Profit Margin	2.77%	↓ 0.92%

	FY19	Y/Y Change
Profit	$42.1M	-

	FY20	Y/Y Change
Profit	$58.2M	↑ 38.37%

	FY21	Y/Y Change
Profit	$79.9M	↑ 37.19%

	FY22	Y/Y Change
Profit	$103.2M	↑ 29.3%

	FY23	Y/Y Change
Profit	$116.9M	↑ 13.22%

	Q2 FY23	Q/Q Change
Profit	$28.5M	↑ 3.05%

	Q3 FY23	Q/Q Change
Profit	$29.9M	↑ 4.69%

	Q4 FY23	Q/Q Change
Profit	$30.9M	↑ 3.39%

	Q1 FY24	Q/Q Change
Profit	$31.9M	↑ 3.29%

	Q2 FY24	Q/Q Change
Profit	$33.5M	↑ 5.07%

	Q3 FY24	Q/Q Change
Profit	$34.8M	↑ 3.98%

	FY19	Y/Y Change
Operating Cash Flow	$12.3M	-
Investing Cash Flow	$-4.4M	-
Financing Cash Flow	$-7.5M	-

	FY20	Y/Y Change
Operating Cash Flow	$1.7M	↓ 86.47%
Investing Cash Flow	$-5.1M	↑ 14.43%
Financing Cash Flow	$11.6M	↓ 253.28%

	FY21	Y/Y Change
Operating Cash Flow	$-318.0K	↓ 119.1%
Investing Cash Flow	$-8.0M	↑ 58.13%
Financing Cash Flow	$58.8M	↑ 409.12%

	FY22	Y/Y Change
Operating Cash Flow	$14.2M	↓ 4551.57%
Investing Cash Flow	$-7.9M	↓ 1.04%
Financing Cash Flow	$-8.0M	↓ 113.52%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$6.0M	↑ 551.3%
Investing Cash Flow	$-2.2M	↓ 12.98%
Financing Cash Flow	$-30.8M	↑ 385.47%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$12.1M	↑ 101.16%
Investing Cash Flow	$-2.6M	↑ 17.49%
Financing Cash Flow	$-5.3M	↓ 82.79%

Enfusion Technicals Summary

Sell

Neutral

Buy

Enfusion is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Enfusion Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Enfusion Inc	5.59%	24.18%	7.63%	-46.78%	-46.59%
Shopify Inc.	-1.7%	66.81%	39.27%	-19.91%	177.98%
Uber Technologies, Inc.	-13.76%	-15.09%	-2.26%	45.06%	107.5%
Servicenow, Inc.	3.32%	40.54%	57.38%	69.05%	290.92%
Salesforce Inc	0.36%	33.97%	29.69%	34.83%	112.04%
Intuit Inc.	1.01%	-1.81%	2.75%	-0.69%	145.51%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Enfusion Inc	264.5	264.5	NA	0.21	0.05	0.06	NA	0.75
Shopify Inc.	110.02	110.02	1.12	1.53	0.15	0.06	NA	7.05
Uber Technologies, Inc.	30.4	30.4	0.87	1.87	0.34	0.04	NA	7.02
Servicenow, Inc.	172.47	172.47	2.99	13.91	0.16	0.05	NA	45.03
Salesforce Inc	56.84	56.84	1.54	8.2	0.1	0.05	0.0	61.43
Intuit Inc.	62.89	62.89	1.94	16.83	0.17	0.08	0.01	65.78

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Enfusion Inc	Sell	$998.5M	-46.59%	264.5	1.7%
Shopify Inc.	Buy	$141.3B	177.98%	110.02	16.4%
Uber Technologies, Inc.	Buy	$129.9B	107.5%	30.4	10.49%
Servicenow, Inc.	Buy	$228.1B	290.92%	172.47	12.77%
Salesforce Inc	Buy	$329.6B	112.04%	56.84	15.45%
Intuit Inc.	Buy	$180.6B	145.51%	62.89	18.2%

About Enfusion

enfusion is the leading provider of a cloud-based portfolio management and risk system. headquartered in chicago, illinois, with a branch office in new york, new york, and wholly-owned subsidiaries in london and hong kong, enfusion is a software company that focuses on delivering innovative solutions for clients in the financial services industry. our clients across the globe rely on our innovative real-time performance, risk calculations and accounting for some of the most sophisticated financial products. enfusion is undergoing exceptional growth and currently serves some of the world's largest and respected hedge funds with over 90 billion dollars of assets under management.

Organization	Enfusion
Employees	1102
CEO	Mr. Oleg Movchan
Industry	Technology

Management People of Enfusion

Name	Title
Mr. Oleg Movchan	CEO & Director
Mr. Bradley Herring	Chief Financial Officer
Mr. Neal Pawar	Chief Operating Officer
Mr. Stephen Malherbe	Managing Partner
Ms. Valeria Gutowski	Chief Accounting Officer
Mr. Daniel Groman	Chief Technology Officer
Mr. Ignatius Tochukwu Njoku	Head of Investor Relations
Mr. Matthew R. Campobasso	General Counsel & Corporate Secretary
Ms. Bronwen Bastone	Chief People Officer
Mr. Joseph Defeo	Global Head of Managed Services Production

Important FAQs about investing in Enfusion from India :

What is Enfusion share price today?

Enfusion share price today stands at $10.69, Open: $10.55 ; Previous Close: $10.58 ; High: $11.03 ; Low: $10.48 ; 52 Week High: $11.38 ; 52 Week Low: $7.52. The stock opens at $10.55, after a previous close of $10.58. The stock reached a daily high of $11.03 and a low of $10.48, with a 52-week high of $11.38 and a 52-week low of $7.52.

Can Indians buy Enfusion shares?

Yes, Indians can invest in the Enfusion (ENFN) from India.

With INDmoney, you can buy Enfusion at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Enfusion at zero transaction cost.

How can I buy Enfusion shares from India?

It is very easy to buy Enfusion from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Enfusion be purchased?

Yes, you can buy fractional shares of Enfusion with INDmoney app.

What are the documents required to start investing in Enfusion stocks?

To start investing in Enfusion, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.